Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Garima
    Garima

      Garima joined Medical Dialogues in the year 2017 and is currently working as a Senior Editor. She looks after all the Healthcare news pertaining to Medico-legal cases, MCI/DCI decisions, Medical Education issues, government policies as well as all the news and updates concerning Medical and Dental Colleges in India. She is a graduate from Delhi University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Garima

      Articles By : Garima

      Bayer signs deal with adivo to develop antibodies for veterinary medicine

      Bayer signs deal with adivo to develop antibodies for veterinary medicine

      Garima19 April 2019 9:15 AM IST
      Under the terms of the agreement, Bayer Animal Health will have access to adivo’s species-specific monoclonal antibody technology. Germany: Bayer...
      Abbott Labs first-quarter sales ahead of expectations

      Abbott Labs first-quarter sales ahead of expectations

      Garima19 April 2019 9:00 AM IST
      Abbott Laboratories, whose products range from medical devices to infant nutritional formula posted net earnings of $672 million, or 38 cents per...
      Ministry of AYUSH invites initial bids for strategic sale of IMPCL

      Ministry of AYUSH invites initial bids for strategic sale of IMPCL

      Garima18 April 2019 10:15 AM IST
      If the strategic sale of Indian Medicines Pharmaceutical Corporation Ltd (IMPCL), under the Ministry of AYUSH goes through the proceeds, would add to...
      Cipla acquires 30 percent stake in Brandmed for Rs 32 crore

      Cipla acquires 30 percent stake in Brandmed for Rs 32 crore

      Garima18 April 2019 9:15 AM IST
      The acquisition of Brandmed is expected to complete by May 31. The transaction worth Rs 32 crore will be executed by the company's South African arm...
      Cancer drugs Darzalex, Imbruvica drive JnJ to better than expected quarterly profit

      Cancer drugs Darzalex, Imbruvica drive JnJ to better than expected quarterly profit

      Garima17 April 2019 9:40 AM IST
      JnJ, the first major drugmaker to report first-quarter results, reported a slight rise in quarterly sales to $20.02 billion, above the average...
      Roche ups outlook as sales growth offsets price hit

      Roche ups outlook as sales growth offsets price hit

      Garima17 April 2019 9:00 AM IST
      Drugs division chief Bill Anderson said Roche Pharmaceutical's drug revenue is soaring even as it honours a price-freeze pledge it made last year...
      Cipla, Pulmatrix join hands to co-develop Pulmazole for treating asthma

      Cipla, Pulmatrix join hands to co-develop Pulmazole for treating asthma

      Garima16 April 2019 9:40 AM IST
      Pulmazole an inhaled iSPERSE formulation of the antifungal drug itraconazole for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in...
      Anixa Biosciences extends, expands collaboration with New Jersey Urology

      Anixa Biosciences extends, expands collaboration with New Jersey Urology

      Garima14 April 2019 9:45 AM IST
      New Delhi: Anixa Biosciences, Inc., a biotechnology company focused on using the body's immune system to fight cancer, recently announced that it has...
      Caplin steriles signs license, supply agreement with Baxter for injectable portfolio

      Caplin steriles signs license, supply agreement with Baxter for injectable portfolio

      Garima14 April 2019 9:03 AM IST
      Chennai: Pharma Major, Caplin Point Laboratories said that its wholly owned subsidiary Caplin Steriles Limited has entered into a license and supply...
      Deloitte, Google Cloud to collaborate on transformative solutions for health care

      Deloitte, Google Cloud to collaborate on transformative solutions for health care

      Garima13 April 2019 9:35 AM IST
      New Delhi: Deloitte and Google Cloud recently announced plans to collaborate on next-generation solutions for the life sciences and health care to...
      Gilead Sciences, Novo Nordisk to initiate clinical collaboration for NASH trial

      Gilead Sciences, Novo Nordisk to initiate clinical collaboration for NASH trial

      Garima13 April 2019 9:15 AM IST
      Denmark: Gilead Sciences, Inc. and Novo Nordisk recently announced that the companies intend to collaborate on a clinical trial combining compounds...
      Fortis Healthcare to sell stake in Singapore listed Rs 4650 crore RHT Trust

      Fortis Healthcare to sell stake in Singapore listed Rs 4650 crore RHT Trust

      Garima11 April 2019 1:20 PM IST
      New Delhi: A couple and a month after acquiring the assets of Religare Health Trust (RHT) for Rs 4650 crore, Fortis Healthcare Ltd. (FHL) has now...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok